Laryngopharyngeal Reflux Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-06-01
Clinical Trial Update: The Efficacy of Potassium-competitive Acid Blocker in Patients With Laryngopharyngeal Reflux Disease [Phase 3]
Phase 3 trial updating on the efficacy of a potassium-competitive acid blocker for laryngopharyngeal reflux disease.